about
Combination Chemotherapy in Treating Patients With Advanced Colorectal CancerAtrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerVaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in SurgeryS0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic LeukemiaDuloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With CancerPemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerS0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung CancerAMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine TumorsFulvestrant and Bevacizumab in Treating Patients With Metastatic Breast CancerCitalopram in Treating Postmenopausal Women With Hot FlashesVitamin E in Preventing Peripheral Neuropathy Caused by Chemotherapy in Patients Receiving Chemotherapy for CancerTopical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for CancerBrostallicin and Cisplatin in Treating Patients With Metastatic Breast CancerEarly or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic LeukemiaDasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma MultiformeZoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementBevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver CancerAcute Pain Caused by Paclitaxel in Patients With CancerQuality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast CancerAlpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for CancerBevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerSt. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast CancerABI-007 (Nab-Paclitaxel) and Gemcitabine in Treating Women With Metastatic Breast CancerDocetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast CancerCetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung CancerRadiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast CancerBrachytherapy in Treating Patients With Prostate CancerPiritrexim in Treating Patients With Advanced Cancer of the Urinary TractFludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's LymphomaTheophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic LeukemiaTrastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerRadiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma MultiformeGabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone TherapyComparison of Two Combination Chemotherapy Regimens in Treating Women With Breast CancerCetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerPaclitaxel in Treating Patients With Advanced Head and Neck CancerDocetaxel and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerFlutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the ProstateSWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantCombination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
P6153
Q58407403-3CEFB002-18D8-46B3-90B1-EA547D82000FQ58407407-851DF712-435E-4202-B30E-752A56328A68Q58848851-7ECA6CAA-9523-431F-B996-25EBBCC0AFCEQ61917852-E9E6370A-6534-4524-A09D-977D7349D367Q61918146-C763BCF6-F8E1-4854-A3EF-F724BB1336F4Q61920734-8289DD17-ECC8-4537-91FC-887728608172Q61921083-D301583A-8FBC-42D0-A15E-42844C1BC131Q61921358-2B725109-7233-4574-9A35-B6B77C5ECD6EQ61921646-5D02D711-662F-4ECC-BA18-AF553D00B6F1Q61934602-429B6969-4308-41DD-92BB-5ABF0A5450F5Q61934734-FBDA93CD-2B62-43D0-9DEC-279A58559393Q61934755-3E2CBCFA-F30B-4BF9-BBDF-B8B77F1B1D23Q61937080-BF640463-C537-4B24-A2C9-9F166D4F09B5Q61978936-05729D1E-544B-4E00-AFD9-0DC42714786BQ61980727-BD5D2CCB-3761-47EC-BBCD-C8B2C9F40BC9Q61980743-923B9679-36AF-4C79-BDFA-55E8C4A55C96Q61980906-985B8DCD-7B5E-43E8-9475-303D089A2CA9Q61981551-DB4CB2A0-AB90-4867-AA5B-87F5FF9878B4Q62104750-F6579623-7D90-4427-876B-F6AB200A7E42Q62105002-AB234B00-D494-48A1-ABBC-5D92CAC019C7Q62105042-194B92AC-8C9C-44D7-8522-F30DAB90F82BQ62105295-A7F527AE-80F3-4FB5-A91C-5B67762FC64EQ62105300-CA3469A4-B851-438C-8266-60AF0017F679Q62105614-BC82E1C8-6547-4B2F-8044-D871853C7249Q62106085-279A0647-2C89-41A0-9617-8FFAE86D51F3Q62106094-D58E1432-07D4-4B9A-B999-4901348AB0E9Q62109997-E71D29A5-8F1E-4639-8C44-B2A335412982Q62110025-5D53E56D-7A5D-473F-A6EB-D8DB5A131334Q62110203-6177381A-4610-48F4-94B3-530D78DD6109Q62110274-45E54103-1DBE-40ED-8EA2-618ACDE59ED3Q62110331-EE09823E-6C74-44A3-9BE2-B2078F5A8410Q62110352-27D08C27-772C-4A37-8D9A-E9D0155F91CBQ62110412-993D0CE8-BAC1-4560-9572-ECBB1EDDAFFAQ62110429-F187AF17-5E77-4AD0-BFF1-70350BF468B8Q62110464-AFD91C4E-0D1F-44B3-AA77-369BBDB7EEFFQ62110506-3D4A0147-DB38-4F9C-9C50-64258882524FQ62110572-98B0E96D-39F8-4EFA-A94E-4A88ED7A8E7DQ62110597-605944EF-8AA7-4CA2-93A3-2F35D4D317C2Q62110602-060D2BD2-8483-4534-AAC9-650BA30C553BQ62110638-491AB553-5249-4538-A0F5-6AD2C71CA1F2
P6153
description
amerikanische Non-Profit-Organisation
@de
nonprofit organization in Saint Louis Park, United States
@en
name
Metro-Minnesota Community Oncology Research Consortium
@en
type
label
Metro-Minnesota Community Oncology Research Consortium
@en
altLabel
MMCORC
@en
Metro-Minnesota Community Clinical Oncology
@en
prefLabel
Metro-Minnesota Community Oncology Research Consortium
@en
P131
P2427
grid.476964.e
P571
1979-01-01T00:00:00Z
P625
Point (-93.345769 44.933652)